purified water

DRUG8 trials

Sponsors

Inventiva, Odense University Hospital, Klinikum der Technischen Universitaet Muenchen (TUM Klinikum), The Calcutta Medical Research Institute, Nitric BioTherapeutics, Inc

Conditions

Birch pollen AllergyChronic Rhinosinusitis (Diagnosis)Dental FluorosisHealth Condition 1: null- Those undergoing cataract surgery by standard phacoemulsification and hydrophobic foldable intraocular lens implantationKidney transplant recipientsModerate to severe obstructive sleep apnea with chronic rhinitis Moderate to severe obstructive sleep apnea chronic rhinitis apnea hypopnea index intranasal steroidNon-alcoholic steatohepatitis (NASH)Onychomycosis

Phase 1

Systemic Fluoride Bioavailability From Toothpastes Containing Calcium Carbonate or Silica as Abrasives

CompletedNCT01571050

University of Campinas, BrazilDental Fluorosis

Start: 2011-01-31End: 2011-12-31Updated: 2012-04-04

Silver Nanoparticle Investigation for Treating Chronic Sinusitis

WithdrawnNCT03243201

Washington University School of MedicineChronic Rhinosinusitis (Diagnosis)

Start: 2018-01-31End: 2018-12-31Updated: 2018-05-11

Phase 2

Efficacy and Safety Study of Iontophoretic Application of Terbinafine Gel in Subjects With Onychomycosis

CompletedNCT01080079

Nitric BioTherapeutics, IncOnychomycosis

Start: 2010-05-31End: 2012-06-30Updated: 2012-10-19

SGL-TX-PTDM: SGLT2i effect on PTDM development and kidney allograft function in kidney transplant recipients: A randomized, double-blind, placebo controlled, national multicenter trial

Not yet recruitingCTIS2024-518774-14-00

Odense University HospitalKidney transplant recipients

Target: 184Updated: 2026-03-09

Sublingual Birch Immunotherapy for Pollen-associated Food Allergy

Not yet recruitingCTIS2025-523653-34-00

Klinikum der Technischen Universitaet Muenchen (TUM Klinikum)Birch pollen Allergy, Pollen-associated Food Allergy

Target: 96Updated: 2026-05-29

Phase 3

A randomised, double-blind, placebo-controlled, multicentre, Phase 3 study evaluating efficacy and safety of lanifibranor followed by an active treatment extension in adult patient with non-cirrhotic non-alcoholic steatohepatitis (NASH) and fibrosis 2 (F2)/fibrosis 3 (F3) stage of liver fibrosis

Active, not recruitingCTIS2023-508248-23-00

InventivaNon-alcoholic steatohepatitis (NASH)

Start: 2021-11-26Target: 236Updated: 2025-11-10

Unknown Phase

Need for steroid use after routine cataract surgery

Active, not recruitingCTRI/2016/04/006806

The Calcutta Medical Research InstituteHealth Condition 1: null- Those undergoing cataract surgery by standard phacoemulsification and hydrophobic foldable intraocular lens implantation

Target: 240Updated: 2021-11-24

A randomized, placebo controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis

Active, not recruitingTCTR20180614004

NONEModerate to severe obstructive sleep apnea with chronic rhinitis Moderate to severe obstructive sleep apnea chronic rhinitis apnea hypopnea index intranasal steroid

Start: 2018-05-30Updated: 2026-06-22